Human Investing LLC Cuts Stock Position in Amdocs Limited (NASDAQ:DOX)

Human Investing LLC lessened its holdings in Amdocs Limited (NASDAQ:DOXFree Report) by 16.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,608 shares of the technology company’s stock after selling 900 shares during the period. Human Investing LLC’s holdings in Amdocs were worth $392,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Nordea Investment Management AB increased its stake in Amdocs by 8.3% during the 4th quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company’s stock worth $141,112,000 after buying an additional 127,426 shares during the period. Mirabella Financial Services LLP increased its stake in Amdocs by 204.2% during the 3rd quarter. Mirabella Financial Services LLP now owns 14,302 shares of the technology company’s stock worth $1,250,000 after buying an additional 9,600 shares during the period. Victory Capital Management Inc. increased its stake in Amdocs by 1.9% during the 3rd quarter. Victory Capital Management Inc. now owns 478,137 shares of the technology company’s stock worth $41,827,000 after buying an additional 9,098 shares during the period. Pacer Advisors Inc. increased its stake in Amdocs by 7.4% during the 4th quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company’s stock worth $154,587,000 after buying an additional 125,654 shares during the period. Finally, Crossmark Global Holdings Inc. increased its stake in Amdocs by 34.7% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 145,556 shares of the technology company’s stock worth $12,733,000 after buying an additional 37,516 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of DOX stock opened at $88.30 on Monday. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The firm has a fifty day moving average of $85.89 and a two-hundred day moving average of $86.47. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The firm has a market cap of $9.97 billion, a P/E ratio of 20.49, a P/E/G ratio of 1.41 and a beta of 0.71.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. As a group, research analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Stockholders of record on Monday, March 31st will be issued a $0.527 dividend. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a dividend yield of 2.39%. Amdocs’s payout ratio is 44.55%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DOX shares. Oppenheimer lifted their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. StockNews.com raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Finally, Barclays decreased their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Amdocs has an average rating of “Buy” and an average target price of $101.20.

Get Our Latest Stock Analysis on Amdocs

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.